Emmanuelle Trombe, Anthony Paronneau and Raphaëlle Monjou advised French biopharmaceutical company Inventiva on a collaboration and licensing partnership agreement with Boehringer Ingelheim to develop a new exploratory treatment against idiopathic pulmonary fibrosis.